🎁 Black Friday: up to 50% off of annual plans
BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.60
-2.60 (-8.07%)
At close: Nov 20, 2026

BIONET Therapeutics Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
69.9399.5221.9745.353.97
Short-Term Investments
922.659361,155458-
Trading Asset Securities
24.3124.4537.7221.02-
Cash & Short-Term Investments
1,0171,0601,215524.3253.97
Cash Growth
-4.06%-12.74%131.67%871.44%-
Accounts Receivable
31.5527.5715.111.17-
Other Receivables
10.718.236.591.6-
Receivables
42.2635.821.72.77-
Inventory
55.9630.0829.520.37-
Prepaid Expenses
9.2411.878.980.890.15
Other Current Assets
-0.090.09--
Total Current Assets
1,1241,1381,275528.3554.12
Property, Plant & Equipment
138.94138.5154.228.72-
Long-Term Investments
5.172.754.92--
Other Intangible Assets
2.462.830.36--
Other Long-Term Assets
2.861.1815.553.11-
Total Assets
1,2741,2831,350540.1854.12

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
11.567.9716.845.230.68
Accrued Expenses
-25.813.563.394.65
Current Portion of Leases
5.821.02---
Current Unearned Revenue
21.9811.34.322.61-
Other Current Liabilities
30.9911.6818.980.860.09
Total Current Liabilities
70.3657.7753.712.095.42
Long-Term Leases
16.79.88---
Total Liabilities
87.0567.6553.712.095.42

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
700700700450.2956
Additional Paid-In Capital
-712.7716.29124.86-
Retained Earnings
-273.88-231.12-133.7-47.44-7.3
Comprehensive Income & Other
760.5833.8313.730.38-
Shareholders' Equity
1,1871,2151,296528.0948.7
Total Liabilities & Equity
1,2741,2831,350540.1854.12

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
22.5210.9---
Net Cash (Debt)
994.361,0491,215524.3253.97
Net Cash Growth
-5.21%-13.63%131.67%871.44%-
Net Cash Per Share
14.1914.9921.1534.7449.29
Filing Date Shares Outstanding
68.477070701.1
Total Common Shares Outstanding
68.47707045.031.1
Working Capital
1,0541,0801,221516.2648.7
Book Value Per Share
17.3317.3618.5211.7344.47
Tangible Book Value
1,1841,2131,296528.0948.7
Tangible Book Value Per Share
17.3017.3218.5111.7344.47
Machinery
-88.2435.349.3-
Construction In Progress
--22.6--
Leasehold Improvements
-53.87---